CLINICAL_TRIALS
trial_result
· 2019-10-22
Clinical Trial Update: Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough [Phase 2]
Summary
Phase 2 trial evaluating serlopitant for refractory chronic cough has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vyne Therapeutics Inc. | Conditions: Refractory Chronic Cough | Phase 2 | Status: COMPLETED | Results posted: 2019-10-22